Search Results - "Brondon, Jennifer E."
-
1
Repurposing of antiangiogenic agents for treatment of vascular anomalies
Published in Pharmacology & therapeutics (Oxford) (01-10-2023)“…Vascular anomalies (VA) are developmental anomalies of veins, arteries, lymphatics or capillaries thought to be caused by mutations in genes that drive…”
Get full text
Journal Article -
2
Safety and feasibility of umbilical cord blood transplantation in children with neuronal ceroid lipofuscinosis: a retrospective study
Published in Stem cells translational medicine (29-10-2024)“…Ceroid lipofuscinosis neuronal (CLN) encompasses rare inherited neurodegenerative disorders that present in childhood with clinical features including…”
Get full text
Journal Article -
3
Outcomes of pediatric patients with therapy-related myeloid neoplasms
Published in Bone marrow transplantation (Basingstoke) (01-12-2021)“…Long-term outcomes after allogeneic hematopoietic cell transplantation (HCT) for therapy-related myeloid neoplasms (tMNs) are dismal. There are few multicenter…”
Get full text
Journal Article -
4
Staphylococcus aureus Bloodstream Infection Due to Contaminated Hematopoietic Stem-Cell Graft
Published in Infection control and hospital epidemiology (01-03-2018)“…To the Editor—The Foundation for the Accreditation of Cellular Therapy and the American Association of Blood Banks publish guidelines to ensure the quality and…”
Get full text
Journal Article -
5
Outcomes of Umbilical Cord Blood Transplantation in Children with Batten Disease
Published in Biology of blood and marrow transplantation (01-03-2019)“…Neuronal ceroid lipofuscinoses (NCL, Batten Disease) are a class of lysosomal storage diseases caused by mutations in ceroid lipofuscinoses (CLN) genes…”
Get full text
Journal Article -
6
Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients
Published in Biology of blood and marrow transplantation (01-03-2019)“…Despite major advances in hematopoietic cell transplant (HCT), 10-50% of patients relapse following allogeneic HCT. Donor lymphocyte infusion (DLI) is one…”
Get full text
Journal Article -
7
Reduced Intensity Vs Myeloablative Conditioning Regimen for Pediatric Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia
Published in Biology of blood and marrow transplantation (01-03-2019)“…Therapy-related myelodysplastic syndrome and acute myeloid leukemia (t-MDS/AML) are rare but well-recognized complications of cancer therapy. Allogeneic…”
Get full text
Journal Article -
8